Tobias Beschauner studied Biochemistry at Heidelberg University, where he developed a strong interest in cancer biology and the molecular mechanisms that drive disease progression. For his Master’s thesis, he joined the laboratory of Prof. Michael Boutros at the German Cancer Research Center (DKFZ), where he worked on functional drug and genetic screens in patient-derived colorectal cancer models, combining high-throughput approaches with mechanistic follow-up studies. These experiences shaped his interest in interdisciplinary cancer research and functional genomics.

Tobias is now a PhD student in the laboratory of  Anna Obenauf at the Institute of Molecular Pathology (IMP) in Vienna. His research focuses on understanding how cancer cells evade immune surveillance during early metastatic colonisation, with the aim of identifying cancer cell–intrinsic programs that enable tumour cells to persist under immune pressure and eventually form metastases.

As part of the Adaptmet network, Tobias is excited to be embedded in an international and collaborative training environment that bridges cancer biology, immunology, and genomics. He looks forward to expanding his scientific expertise while contributing to a deeper mechanistic understanding of metastasis, and he aims to pursue a future career in preclinical cancer research with a focus on cancer immunotherapy.